Skip to main content
Log in

The feasibility of quantitative assessment of dynamic 18F-fluorodeoxyglucose PET in Takayasu’s arteritis: a pilot study

  • Original Article
  • Published:
European Journal of Nuclear Medicine and Molecular Imaging Aims and scope Submit manuscript

Abstract

Purpose

PET has been demonstrated to be sensitive for detecting active inflammation in Takayasu’s arteritis (TAK) patients, but semi-quantitative-based assessment may be susceptible to various biological and technical factors. Absolute quantification via dynamic PET (dPET) may provide a more reliable and quantitative assessment of TAK-active arteries. The purpose of this study was to investigate the feasibility and efficacy of dPET in quantifying TAK-active arteries compared to static PET.

Materials and methods

This prospective study enrolled 10 TAK-active patients (fulfilled the NIH criteria) and 5 control participants from March to October 2022. One-hour dPET scan (all TAK and control participants) and delayed static PET scan at 2-h (all TAK patients) were acquired. For 1-h static PET, summed images from 50 to 60 min of the dPET were extracted. PET parameters derived from 1- and 2-h static PET including SUV (SUV1H and SUV2H), target-to-background ratio (TBR) (TBR1H and TBR2H), net influx rate (Ki), and TBRKi extracted from dPET were obtained. The detectability of TAK-active arteries was compared among different scanning methods using the generalized estimating equation (GEE) with a logistic regression with repeated measures, and the GEE with gamma distribution and log link function was used to evaluate the different study groups or scanning methods.

Results

Based on the disease states, 5 cases of TAK were classified as untreated and relapsed, respectively. The SUVmax on 2-h PET was higher than that on 1-h PET in the untreated patients (P < 0.05). However, no significant differences were observed in the median SUVmax between 1-h PET and 2-h PET in the relapsed patients (P > 0.05). The TBRKi was significantly higher than both TBR1H and TBR2H (all P < 0.001). Moreover, the detectability of TAK-active arteries by dPET-derived Ki was significantly higher than 1-h and 2-h PET (all P < 0.001). Significant differences were observed in Kimax, SUVmax-1H, TBR1H, and TBRKi among untreated, relapsed, and control groups (all P < 0.05).

Conclusions

Absolute quantitative assessment by dPET provides an improved sensitivity and detectability in both visualization and quantification of TAK-active arteries. This elucidates the clinical significance of dPET in the early detection of active inflammation and monitoring recurrence.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

Data availability

Data are available on request to the corresponding author.

Code availability

Not applicable.

Abbreviations

TAK:

Takayasu’s arteritis

[18F]FDG:

2-Deoxy-2-[18F]fluoro-D-glucose

PET:

Positron emission tomography

SUV:

Standardized uptake value

TBR:

Target-to-background ratio

SNR:

Signal-to-noise ratio

References

  1. Ishikawa K, Maetani S. Long-term outcome for 120 Japanese patients with Takayasu’s disease. Clinical and statistical analyses of related prognostic factors. Circulation. 1994;90:1855–60.

    Article  CAS  PubMed  Google Scholar 

  2. Grayson PC, Ponte C, Suppiah R, et al. 2022 American College of Rheumatology/EULAR classification criteria for Takayasu arteritis. Ann Rheum Dis. 2022;81(12):1654–60.

    Article  PubMed  Google Scholar 

  3. de Souza AW, de Carvalho JF. Diagnostic and classification criteria of Takayasu arteritis. J Autoimmun. 2014;48–49:79–83.

    Article  PubMed  Google Scholar 

  4. Vaidyanathan S, Patel CN, Scarsbrook AF, Chowdhury FU. FDG PET/CT in infection and inflammation—current and emerging clinical applications. Clin Radiol. 2015;70(7):787–800.

    Article  CAS  PubMed  Google Scholar 

  5. Einspieler I, Thürmel K, Pyka T, et al. Imaging large vessel vasculitis with fully integrated PET/MRI: A pilot study. Eur J Nucl Med Mol Imaging. 2015;42(7):1012–24.

    Article  CAS  PubMed  Google Scholar 

  6. Gheysens O, Jamar F, Glaudemans AWJM, Yildiz H, van der Geest KSM. Semi-quantitative and quantitative [18F]FDG-PET/CT indices for diagnosing large vessel vasculitis: A critical review. Diagnostics (Basel). 2021;11(12):2355.

    Article  CAS  PubMed  Google Scholar 

  7. Adams MC, Turkington TG, Wilson JM, Wong TZ. A systematic review of the factors affecting accuracy of SUV measurements. AJR Am J Roentgenol. 2010;195:310–20.

    Article  PubMed  Google Scholar 

  8. Choi JY, Yang J, Noworolski SM, et al. 18F fluorocholine dynamic time-of-flight PET/MR imaging in patients with newly diagnosed intermediate- to high-risk prostate cancer: Initial clinical-pathologic comparisons. Radiology. 2017;282(2):429–36.

    Article  PubMed  Google Scholar 

  9. Wardak M, Sonni I, Fan AP, et al. 18F-FSPG PET/CT imaging of system xC- transporter activity in patients with primary and metastatic brain tumors. Radiology. 2022;303(3):620–31.

    Article  PubMed  Google Scholar 

  10. Wang Y, Li E, Cherry SR, Wang G. Total-body PET kinetic modeling and potential opportunities using deep learning. PET clinics. 2021;16:613–25.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Spencer BA, Berg E, Schmall JP, et al. Performance evaluation of the uEXPLORER total-body PET/CT scanner based on NEMA NU 2–2018 with additional tests to characterize pet scanners with a long axial field of view. J Nucl Med. 2021;62(6):861–70.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Cherry SR, Badawi RD, Karp JS, Moses WW, Price P, Jones T. Total-body imaging: Transforming the role of positron emission tomography. Sci Transl Med. 2017;9(381):eaaf6169.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Sari H, Mingels C, Alberts I, et al. First results on kinetic modelling and parametric imaging of dynamic 18F-FDG datasets from a long axial FOV PET scanner in oncological patients. Eur J Nucl Med Mol Imaging. 2022;49(6):1997–2009.

    Article  CAS  PubMed  Google Scholar 

  14. Duan Y, Wang X, Cheng Z. Immunoglobulin G4-related aortitis/periaortitis: Total-body 18F-fluorodeoxyglucose positron emission tomography dynamic imaging. Circ Cardiovasc Imaging. 2023;16(3): e014176.

    PubMed  Google Scholar 

  15. Sharma BK, Jain S, Suri S, Numano F. Diagnostic criteria for Takayasu arteritis. Int J Cardiol. 1996;54:S141–7.

    Article  PubMed  Google Scholar 

  16. Arend WP, Michel BA, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthritis Rheum. 1990;33:1129–34.

    Article  CAS  PubMed  Google Scholar 

  17. Kerr GS, Hallahan CW, Giordano J, et al. Takayasu arteritis. Ann Intern Med. 1994;120(11):919–29.

    Article  CAS  PubMed  Google Scholar 

  18. Maz M, Chung SA, Abril A, et al. 2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Giant Cell Arteritis and Takayasu Arteritis. Arthritis Rheumatol. 2021;73(8):1349–65. https://doi.org/10.1002/art.41774.

    Article  PubMed  Google Scholar 

  19. Grayson PC, Alehashemi S, Bagheri AA, et al. 18 F-fluorodeoxyglucose-positron emission tomography as an imaging biomarker in a prospective, longitudinal cohort of patients with large vessel vasculitis. Arthritis Rheumatol. 2018;70(3):439–49.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Incerti E, Tombetti E, Fallanca F, et al. 18F-FDG PET reveals unique features of large vessel inflammation in patients with Takayasu’s arteritis. Eur J Nucl Med Mol Imaging. 2017;44(7):1109–18.

    Article  CAS  PubMed  Google Scholar 

  21. Quinn KA, Rosenblum JS, Rimland CA, Gribbons KB, Ahlman MA, Grayson PC. Imaging acquisition technique influences interpretation of positron emission tomography vascular activity in large-vessel vasculitis. Semin Arthritis Rheum. 2020;50(1):71–6.

    Article  CAS  PubMed  Google Scholar 

  22. Martínez-Rodríguez I, del Castillo-Matos R, Quirce R, et al. Comparison of early (60 min) and delayed (180 min) acquisition of 18F-FDG PET/CT in large vessel vasculitis. Rev Esp Med Nucl Imagen Mol. 2013;32(4):222–6.

    PubMed  Google Scholar 

  23. Dias AH, Pedersen MF, Danielsen H, Munk OL, Gormsen LC. . Clinical feasibility and impact of fully automated multiparametric PET imaging using direct Patlak reconstruction: Evaluation of 103 dynamic whole-body 18F-FDG PET/CT scans [published correction appears in Eur J Nucl Med Mol Imaging. 2021 Feb 13;]. Eur J Nucl Med Mol Imaging. 2021;48(3):837–50.

    Article  PubMed  Google Scholar 

  24. Cheng G, Alavi A, Lim E, Werner TJ, Del Bello CV, Akers SR. Dynamic changes of FDG uptake and clearance in normal tissues. Mol Imaging Biol. 2013;15(3):345–52.

    Article  PubMed  Google Scholar 

  25. Tezuka D, Haraguchi G, Ishihara T, et al. Role of FDG PET-CT in Takayasu arteritis: Sensitive detection of recurrences. JACC Cardiovasc Imaging. 2012;5(4):422–9.

    Article  PubMed  Google Scholar 

  26. Houshmand S, Salavati A, Segtnan EA, Grupe P, Høilund-Carlsen PF, Alavi A. Dual-time-point imaging and delayed-time-point fluorodeoxyglucose-PET/computed tomography imaging in various clinical settings. PET Clin. 2016;11(1):65–84.

    Article  PubMed  Google Scholar 

  27. Shinya T, Otomi Y, Kubo M, et al. Preliminary clinical assessment of dynamic 18F-fluorodeoxyglucose positron emission tomography/computed tomography for evaluating lymph node metastasis in patients with lung cancer: A prospective study. Ann Nucl Med. 2019;33(6):414–23.

    Article  CAS  PubMed  Google Scholar 

  28. Dimitrakopoulou-Strauss A, Pan L, Sachpekidis C. Kinetic modeling and parametric imaging with dynamic PET for oncological applications: General considerations, current clinical applications, and future perspectives. Eur J Nucl Med Mol Imaging. 2021;48(1):21–39.

    Article  PubMed  Google Scholar 

  29. Fu F, Li X, Wu Y, et al. Total-body dynamic PET/CT of micro-metastatic lymph node in a patient with lung cancer. Eur J Nucl Med Mol Imaging. 2021;48:1678–9.

    Article  PubMed  Google Scholar 

  30. Kobayashi Y, Ishii K, Oda K, et al. Aortic wall inflammation due to Takayasu arteritis imaged with 18F-FDG PET coregistered with enhanced CT. J Nucl Med. 2005;46(6):917–22.

    PubMed  Google Scholar 

  31. Incerti E, Tombetti E, Fallanca F, et al. (18)F-FDG PET reveals unique features of large vessel inflammation in patients with Takayasu’s arteritis. Eur J Nucl Med Mol Imaging. 2017;44:1109–18.

    Article  CAS  PubMed  Google Scholar 

  32. Barra L, Kanji T, Malette J, Pagnoux C; CanVasc. Imaging modalities for the diagnosis and disease activity assessment of Takayasu’s arteritis: A systematic review and meta-analysis. Autoimmun Rev. 2018;17(2):175–187.

Download references

Acknowledgements

We would like to thank Qi Ge (Central Research Institute, UIH Group) for her valuable advice and support on the statistical analysis of the data.

Funding

This study was supported by National Natural Science Foundation of China Grants (82202235), Natural Science Foundation of Shandong Province (ZR2022MH165) and the Academic Promotion Program of Shandong First Medical University (2019LJ005).

Author information

Authors and Affiliations

Authors

Contributions

Study conception and design: Yanhua Duan, Li Chen, Ximing Wang and Zhaoping Cheng. Material preparation, data collection and analysis were performed by Yanhua Duan, Keyu Zan, Minjie Zhao, Yee Ling Ng, Hui Li, Min Ge, Leiying Chai, Xiao Cui, Wenjin Quan and Kun Li. The first draft of the manuscript was written by Yanhua Duan, and all authors commented on previous versions of the manuscript. Manuscript revision: Yun Zhou, Li Chen, Ximing Wang and Zhaoping Cheng. All authors commented on previous versions of the manuscript and read and approved the final manuscript.

Corresponding authors

Correspondence to Li Chen, Ximing Wang or Zhaoping Cheng.

Ethics declarations

Ethics approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. This prospective study was performed from March 2022 to October 2022 with approval from the Hospital Ethics Committee (no.2022-S377).

Consent to participate

All the enrolled patients have signed the informed consent prior to the examination.

Consent for publication

Patients signed informed consent regarding publishing their data and photographs for scientific use.

Conflict of interest

Y.Ng. and Y.Z. are full-time employees of United Imaging Healthcare, China, and have no relevant financial or non-financial interests to disclose. All the other authors have no relevant financial or non-financial interests to disclose.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Yanhua Duan is first author.

Key points

dPET-derived Ki demonstrated a higher detectability of active arteries than static PET-derived SUVs in both untreated (69.5% vs 49.5% vs 36.8%, respectively, P < 0.001) and relapsed Takayasu’s arteritis patients (69.5% vs 42.1% vs 16.8%, respectively, P < 0.001).

dPET is feasible in a clinical setting and the utilization of quantitative dPET-derived TBR proves to be a more sensitive parameter compared to static PET-derived TBRs in both untreated and relapsed patients (all P < 0.001).

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 20 KB)

Supplementary file2 (MP4 1962 KB)

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Duan, Y., Zan, K., Zhao, M. et al. The feasibility of quantitative assessment of dynamic 18F-fluorodeoxyglucose PET in Takayasu’s arteritis: a pilot study. Eur J Nucl Med Mol Imaging 51, 81–92 (2023). https://doi.org/10.1007/s00259-023-06429-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00259-023-06429-4

Keywords

Navigation